Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026

Same author

From Barriers to Bridges: Oncology Nursing in Low and Medium HDI Contexts.

Seminars in oncology nursing·2026

Same author

Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

Health technology assessment (Winchester, England)·2026

Same author

Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe.

Journal of comparative effectiveness research·2026

Same author

Biological, Radiological, and Clinical Significance of Spotty Calcification in Coronary Artery Disease.

JACC. Cardiovascular imaging·2026

Same author

Protein-corrected salivary iodide as a potential biomarker of individual iodine status: a proof-of-concept comparison with urinary iodine in groups with contrasting iodine intake.

The British journal of nutrition·2026

Search research articles

Related Experiment Video

Updated: May 20, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Thrombosis and cancer.

Annie Young¹, Oliver Chapman, Carole Connor

¹Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK. annie.young@ warwick.ac.uk

Nature Reviews. Clinical Oncology

|July 11, 2012

Summary

This summary is machine-generated.

Venous thromboembolism (VTE), a serious condition, is more frequent and recurrent in cancer patients. Effective VTE management, including anticoagulation, may improve survival and outcomes in this population.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Related Experiment Videos

Last Updated: May 20, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Area of Science:

Oncology
Hematology
Clinical Medicine

Background:

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality, particularly in cancer patients.
Cancer patients exhibit increased VTE frequency and recurrence rates compared to other groups.
VTE can be the presenting symptom of occult malignancy and is the second leading cause of death in cancer patients.

Purpose of the Study:

To explore the link between cancer and VTE.
To investigate the impact of VTE on mortality in cancer patients undergoing chemotherapy.
To evaluate the potential benefits of anticoagulation in improving long-term survival in cancer patients.

Main Methods:

Review of existing literature and guidelines on VTE in cancer.
Analysis of risk factors for cancer-related VTE, including tumor type, surgery, chemotherapy, and central venous catheters.
Emerging research on individual VTE predictors.

Main Results:

Cancer patients with symptomatic VTE during chemotherapy face a higher risk of early mortality.
Anticoagulation is being investigated for its potential to improve survival through direct tumor biology modification.
Established guidelines emphasize effective VTE strategies for cancer patients.

Conclusions:

Optimal risk assessment and adherence to VTE prophylaxis and treatment guidelines are crucial.
Clinical teams, in collaboration with patients and caregivers, can enhance outcomes through effective VTE management.
Further research into anticoagulation's role in cancer survival is warranted.